FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310860260> ?p ?o ?g. }

• W4310860260 endingPage "109402" @default.
• W4310860260 startingPage "109402" @default.
• W4310860260 abstract "In a series of our preclinical studies, we have reported that conditioning of α/β CD8+ T cells in vitro with interleukin-12 (IL-12) during their expansion improves their homing phenotype and anti-tumor cytolytic function upon their adoptive transfer in vivo. Vγ9+Vδ2+ T cells can also be expanded in vitro with amino bisphosphonates such as zoledronate (ZOL) for the purpose of adoptive therapy.We aimed in this study to use IL-12 to enhance the expansion and cytotoxic functions of ZOL-expanded Vγ9+Vδ2+T cells.Peripheral blood mononuclear cells (PBMCs) were separated from healthy donors and stage II breast cancer patients. PBMCs (1 × 106 cells/mL) were cultured and treated with ZOL/IL2, ZOL/IL2/IL12, or IL2/IL12. Cultured cells were harvested on days 7 and 14 of culture and their numbers, phenotype, and cytolytic activity were assessed. The levels of pro- and inflammatory cytokines/chemokines in the plasma and supernatants of the cultured cells were analyzed by Luminex.In healthy subjects, the addition of IL-12 to ZOL/IL2-stimulated PBMCs increased the expansion and the cytotoxic activity of Vγ9+Vδ2+ T cells on days 7 and 14 of culture. The latter was measured by the expression level of the cytolytic molecules granzyme B (GZB) and perforin (PER). Of note, αβ CD8 + T cells were also activated under the same condition but with a lesser extent addition of IL-12 to ZOL/IL2-stimulated PBMCs from cancer patients also induced similar effects but were lower than in control subjects. Interestingly, ZOL/IL2/IL12-treated PBMCs showed higher levels of cytokines/chemokines, in particular, CCL, CCL4, GM-CSF, IL-1rα; IL-12, IL-13, TNF, and IFNγ measured on days 7 and 14.The addition of IL12 at the start of the expansion protocol can enhance the activity of γδ T cells which might be mediated in part by the activation of αβ T cells." @default.
• W4310860260 created "2022-12-19" @default.
• W4310860260 creator A5030471228 @default.
• W4310860260 creator A5040959361 @default.
• W4310860260 creator A5048661067 @default.
• W4310860260 creator A5068056600 @default.
• W4310860260 date "2023-01-01" @default.
• W4310860260 modified "2023-10-16" @default.
• W4310860260 title "IL-12 conditioning of peripheral blood mononuclear cells from breast cancer patients promotes the zoledronate-induced expansion of γδ T cells in vitro and enhances their cytotoxic activity and cytokine production" @default.
• W4310860260 cites W1506337752 @default.
• W4310860260 cites W1544477391 @default.
• W4310860260 cites W1610828262 @default.
• W4310860260 cites W1646384754 @default.
• W4310860260 cites W1764179577 @default.
• W4310860260 cites W1830478373 @default.
• W4310860260 cites W1920167267 @default.
• W4310860260 cites W1922412259 @default.
• W4310860260 cites W1949259689 @default.
• W4310860260 cites W1978076091 @default.
• W4310860260 cites W1979514172 @default.
• W4310860260 cites W1979754217 @default.
• W4310860260 cites W1986369171 @default.
• W4310860260 cites W1986699786 @default.
• W4310860260 cites W2006178861 @default.
• W4310860260 cites W2006382856 @default.
• W4310860260 cites W2011475404 @default.
• W4310860260 cites W2013889679 @default.
• W4310860260 cites W2015874075 @default.
• W4310860260 cites W2018540827 @default.
• W4310860260 cites W2027271725 @default.
• W4310860260 cites W2046829925 @default.
• W4310860260 cites W2053665503 @default.
• W4310860260 cites W2058222130 @default.
• W4310860260 cites W2059689009 @default.
• W4310860260 cites W2067217871 @default.
• W4310860260 cites W2073863670 @default.
• W4310860260 cites W2087733503 @default.
• W4310860260 cites W2102156468 @default.
• W4310860260 cites W2106417441 @default.
• W4310860260 cites W2109077280 @default.
• W4310860260 cites W2121548063 @default.
• W4310860260 cites W2126694219 @default.
• W4310860260 cites W2138540474 @default.
• W4310860260 cites W2143939516 @default.
• W4310860260 cites W2144247138 @default.
• W4310860260 cites W2153300538 @default.
• W4310860260 cites W2154720522 @default.
• W4310860260 cites W2162222767 @default.
• W4310860260 cites W2180552802 @default.
• W4310860260 cites W2298831478 @default.
• W4310860260 cites W2404210205 @default.
• W4310860260 cites W2538738981 @default.
• W4310860260 cites W2546649885 @default.
• W4310860260 cites W2607794756 @default.
• W4310860260 cites W2724769065 @default.
• W4310860260 cites W2799682126 @default.
• W4310860260 cites W2889082173 @default.
• W4310860260 cites W2899542051 @default.
• W4310860260 cites W2939955202 @default.
• W4310860260 cites W2968373163 @default.
• W4310860260 cites W3027268760 @default.
• W4310860260 cites W3088921266 @default.
• W4310860260 cites W3158771720 @default.
• W4310860260 cites W3162660398 @default.
• W4310860260 cites W4236657450 @default.
• W4310860260 doi "https://doi.org/10.1016/j.intimp.2022.109402" @default.
• W4310860260 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36481526" @default.
• W4310860260 hasPublicationYear "2023" @default.
• W4310860260 type Work @default.
• W4310860260 citedByCount "0" @default.
• W4310860260 crossrefType "journal-article" @default.
• W4310860260 hasAuthorship W4310860260A5030471228 @default.
• W4310860260 hasAuthorship W4310860260A5040959361 @default.
• W4310860260 hasAuthorship W4310860260A5048661067 @default.
• W4310860260 hasAuthorship W4310860260A5068056600 @default.
• W4310860260 hasConcept C129374314 @default.
• W4310860260 hasConcept C137061746 @default.
• W4310860260 hasConcept C149532602 @default.
• W4310860260 hasConcept C154317977 @default.
• W4310860260 hasConcept C167672396 @default.
• W4310860260 hasConcept C185592680 @default.
• W4310860260 hasConcept C202751555 @default.
• W4310860260 hasConcept C203014093 @default.
• W4310860260 hasConcept C2778690821 @default.
• W4310860260 hasConcept C2779968557 @default.
• W4310860260 hasConcept C2780380082 @default.
• W4310860260 hasConcept C502942594 @default.
• W4310860260 hasConcept C55493867 @default.
• W4310860260 hasConcept C71924100 @default.
• W4310860260 hasConcept C8891405 @default.
• W4310860260 hasConceptScore W4310860260C129374314 @default.
• W4310860260 hasConceptScore W4310860260C137061746 @default.
• W4310860260 hasConceptScore W4310860260C149532602 @default.
• W4310860260 hasConceptScore W4310860260C154317977 @default.
• W4310860260 hasConceptScore W4310860260C167672396 @default.
• W4310860260 hasConceptScore W4310860260C185592680 @default.
• W4310860260 hasConceptScore W4310860260C202751555 @default.
• W4310860260 hasConceptScore W4310860260C203014093 @default.

• next